About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Meditation in Inflammatory Dermatosis | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT05500794

Meditation in Inflammatory Dermatosis

Psoriasis and atopic dermatitis are multifactorial inflammatory dermatoses, with a very high prevalence, reaching more than 120 million patients in the world. Although the physiopathological mechanism...

Lead sponsor: Assistance Publique - Hôpitaux de Paris•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Charles CASSIUS, Dr

CONTACT

+331.42.38.50.49 charles.cassius@aphp.fr

Jérôme Lambert, Pr

CONTACT

+33142499742 jerome.lambert@u-paris.fr

Sponsors

Lead Sponsor

Assistance Publique - Hôpitaux de Paris

Age

0 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient aged 18 years old or older
•With health insurance coverage
•Significant pruritus defined by a Visual Analogical Scale (VAS) pruritus ≥ 4
•Patient with plaque psoriasis
•* Without joint involvement
•* Mild to moderate severity (PASI\>10)
•* DLQI \> 10
•OR Patient with atopic dermatitis:
•Mild to moderate severity (SCORAD\>10)
•DLQI \> 10
•Diagnosis according to Hanifin and Raijka criteria
•* Patient in a stable psychological state
•* French langage spoken

Exclusion Criteria

•Current systemic treatment or treatment discontinued within the last month
•Psychiatric illnesses diagnosed according to the DSM-5 or ICD-10 international criteria of psychotic disorder, severe anxiety disorder, depressive disorder with a current depressive episode of severe intensity, bipolar disorder with a current depressive or manic episode
•Taking psychotropic or neuroleptic treatments
•Participation in another interventional research study or being in the exclusion period at the end of a previous study, if applicable
•Patient under AME

Related studies

RECRUITINGPhase 2

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

NCT07217015 · Atopic Dermatitis

RECRUITINGPhase 2

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT07298395 · Atopic Dermatitis (AD)

RECRUITINGPhase 2

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07474792 · Plaque Psoriasis

RECRUITINGPhase 4

Dupilumab De-escalation in Pediatric Atopic Dermatitis

NCT06116526 · Atopic Dermatitis

RECRUITINGPhase 4

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

NCT06857942 · Psoriasis, Overweight or Obesity

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 19, 2024Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment72

Start dateNov 2022

Last updatedSep 19, 2024

Condition

Atopic Dermatitis Psoriasis Pruritus

Locations shown

Hôpital Saint-Louis

Paris

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions